{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:29:28Z","timestamp":1787563768192,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s11695-023-06998-1","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T19:03:00Z","timestamp":1702926180000},"page":"389-395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Fibrotic NASH in Individuals with Obesity: a Cross-sectional Analysis of the Prevalence of this Significant Milestone of Disease Progression and Accuracy of a Non-invasive Marker for its Screening"],"prefix":"10.1007","volume":"34","author":[{"given":"Lu\u00edsa","family":"de Souza Echeverria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Leandro Saran","family":"Mounzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martinho Antonio","family":"Gestic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murillo Pimentel","family":"Utrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe David Mendon\u00e7a","family":"Chaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Callejas-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinton Adami","family":"Chaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5804-1580","authenticated-orcid":false,"given":"Everton","family":"Cazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"issue":"7","key":"6998_CR1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","volume":"55","author":"J Ludwig","year":"1980","unstructured":"Ludwig J, Viggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55(7):434\u20138.","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"6998_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/0003-4819-126-2-199701150-00008","volume":"126","author":"SG Sheth","year":"1997","unstructured":"Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med. 1997;126(2):137\u201345.","journal-title":"Ann Intern Med"},{"issue":"1","key":"6998_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","volume":"140","author":"CD Williams","year":"2011","unstructured":"Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140(1):124\u201331.","journal-title":"Gastroenterology"},{"issue":"1","key":"6998_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/aje\/kws448","volume":"178","author":"M Lazo","year":"2013","unstructured":"Lazo M, Hernaez R, Eberhardt MS, et al. Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988\u20131994. Am J Epidemiol. 2013;178(1):38\u201345.","journal-title":"Am J Epidemiol"},{"issue":"9","key":"6998_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","volume":"16","author":"V Nobili","year":"2019","unstructured":"Nobili V, Alisi A, Valenti L, et al. NAFLD in children: new genes, new diagnostic modalities and new drugs. Nat Rev Gastroenterol Hepatol. 2019;16(9):517\u201330.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"6998_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/joim.12719","volume":"283","author":"P Dongiovanni","year":"2018","unstructured":"Dongiovanni P, Stender S, Pietrelli A, et al. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. J Intern Med. 2018;283(4):356\u201370.","journal-title":"J Intern Med"},{"issue":"5","key":"6998_CR7","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1002\/hep.31599","volume":"73","author":"EM Brunt","year":"2021","unstructured":"Brunt EM, Kleiner DE, Carpenter DH, et al. American association for the study of liver diseases NASH task force. NAFLD: reporting histologic findings in clinical practice. Hepatology. 2021;73(5):2028\u201338.","journal-title":"Hepatology"},{"issue":"4","key":"6998_CR8","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1053\/j.gastro.2014.07.056","volume":"147","author":"MM Yeh","year":"2014","unstructured":"Yeh MM, Brunt EM. Pathological features of fatty liver disease. Gastroenterology. 2014;147(4):754\u201364.","journal-title":"Gastroenterology"},{"issue":"3","key":"6998_CR9","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s11695-023-06467-9","volume":"33","author":"CW Germano","year":"2023","unstructured":"Germano CW, Mega PF, Mattosinho TJAP, et al. Microvesicular steatosis in individuals with obesity: a histological marker of non-alcoholic fatty liver disease severity. Obes Surg. 2023;33(3):813\u201320.","journal-title":"Obes Surg"},{"issue":"3","key":"6998_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1590\/1516-3180.2016.0306311216","volume":"135","author":"E Cazzo","year":"2017","unstructured":"Cazzo E, Pareja JC, Chaim EA. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review. Sao Paulo Med J. 2017;135(3):277\u201395.","journal-title":"Sao Paulo Med J"},{"key":"6998_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15686","author":"M Franck","year":"2023","unstructured":"Franck M, John K, Al Aoua S, et al. Hepatokine-based identification of fibrotic NASH and improved risk stratification in a multicentre cohort of NAFLD patients. Liver Int. 2023. https:\/\/doi.org\/10.1111\/liv.15686.","journal-title":"Liver Int"},{"issue":"2","key":"6998_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/cld.726","volume":"12","author":"N von Roenn","year":"2018","unstructured":"von Roenn N. Spotlight on impactful research: increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systemic review and meta-analysis. Clin Liver Dis. 2018;12(2):35\u20138 (Hoboken).","journal-title":"Clin Liver Dis"},{"issue":"1","key":"6998_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1590\/s0004-2803.202200001-19","volume":"59","author":"MM Concon","year":"2022","unstructured":"Concon MM, Gestic MA, Utrini MP, et al. Should routine liver biopsy be considered in bariatric surgical practice? An analysis of the limitations of non-invasive NAFLD markers. Arq Gastroenterol. 2022;59(1):110\u20136.","journal-title":"Arq Gastroenterol"},{"issue":"40","key":"6998_CR14","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.3748\/wjg.v25.i40.6053","volume":"25","author":"G Ferraioli","year":"2019","unstructured":"Ferraioli G, Soares Monteiro LB. Ultrasound-based techniques for the diagnosis of liver steatosis. World J Gastroenterol. 2019;25(40):6053\u201362.","journal-title":"World J Gastroenterol"},{"issue":"1089","key":"6998_CR15","doi-asserted-by":"publisher","first-page":"20170959","DOI":"10.1259\/bjr.20170959","volume":"91","author":"YN Zhang","year":"2018","unstructured":"Zhang YN, Fowler KJ, Hamilton G, et al. Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging. Br J Radiol. 2018;91(1089):20170959.","journal-title":"Br J Radiol"},{"issue":"5","key":"6998_CR16","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s10620-016-4037-1","volume":"61","author":"S Kinner","year":"2016","unstructured":"Kinner S, Reeder SB, Yokoo T. Quantitative imaging biomarkers of NAFLD. Dig Dis Sci. 2016;61(5):1337\u201347.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"6998_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jhep.2017.11.028","volume":"68","author":"R Loomba","year":"2018","unstructured":"Loomba R. Role of imaging-based biomarkers in NAFLD: recent advances in clinical application and future research directions. J Hepatol. 2018;68(2):296\u2013304.","journal-title":"J Hepatol"},{"issue":"6","key":"6998_CR18","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116(6):1413\u20139.","journal-title":"Gastroenterology"},{"issue":"3","key":"6998_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"European Association for the Study of the Liver","year":"2021","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update. J Hepatol. 2021;75(3):659\u201389.","journal-title":"J Hepatol"},{"issue":"6","key":"6998_CR20","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.cgh.2022.03.044","volume":"21","author":"F Tavaglione","year":"2023","unstructured":"Tavaglione F, Jamialahmadi O, De Vincentis A, et al. Development and validation of a score for fibrotic nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2023;21(6):1523-1532.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6998_CR21","unstructured":"Sergeant ESG. Epitools epidemiological calculators [Internet]. Freemantle: Ausvet Pty Ltd. 2018. Available from: http:\/\/epitools.ausvet.com.au. Accessed 10 Sep 2023"},{"issue":"15","key":"6998_CR22","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.3390\/jcm11154394","volume":"11","author":"K John","year":"2022","unstructured":"John K, Franck M, Al Aoua S, et al. Non-invasive detection of fibrotic NASH in NAFLD patients with low or intermediate FIB-4. J Clin Med. 2022;11(15):4394.","journal-title":"J Clin Med"},{"issue":"8","key":"6998_CR23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.21037\/atm-20-4354","volume":"9","author":"F Tacke","year":"2020","unstructured":"Tacke F, Weiskirchen R. Non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention. Ann Transl Med. 2020;9(8):729.","journal-title":"Ann Transl Med"},{"issue":"5","key":"6998_CR24","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1002\/hep.29085","volume":"65","author":"PS Dulai","year":"2017","unstructured":"Dulai PS, Singh S, Patel J, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. 2017;65(5):1557\u201365.","journal-title":"Hepatology"},{"issue":"4","key":"6998_CR25","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45(4):846\u201354.","journal-title":"Hepatology"},{"issue":"12","key":"6998_CR26","doi-asserted-by":"publisher","first-page":"CR735","DOI":"10.12659\/MSM.883601","volume":"18","author":"H Cicho\u017c-Lach","year":"2012","unstructured":"Cicho\u017c-Lach H, Celi\u0144ski K, Prozorow-Kr\u00f3l B, et al. The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease. Med Sci Monit. 2012;18(12):CR735-40.","journal-title":"Med Sci Monit"},{"issue":"8","key":"6998_CR27","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1007\/s11695-021-05429-3","volume":"31","author":"LS Jimenez","year":"2021","unstructured":"Jimenez LS, Marques RA, Gestic MA, et al. Non-invasive markers in non-alcoholic fatty liver disease: reliability is variable according to BMI status. Obes Surg. 2021;31(8):3888\u201392.","journal-title":"Obes Surg"},{"issue":"6","key":"6998_CR28","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1007\/s11695-022-06011-1","volume":"32","author":"H Zhou","year":"2022","unstructured":"Zhou H, Luo P, Li P, et al. Bariatric surgery improves nonalcoholic fatty liver disease: systematic review and meta-analysis. Obes Surg. 2022;32(6):1872\u201383.","journal-title":"Obes Surg"},{"issue":"6","key":"6998_CR29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1590\/1516-3180.2021.0828.07012022","volume":"140","author":"F Kreve","year":"2022","unstructured":"Kreve F, Callejas GH, Jimenez LS, et al. Trajectory of NAFLD characteristics after Roux-en-Y gastric bypass: a five-year historical cohort study. Sao Paulo Med J. 2022;140(6):739\u201346.","journal-title":"Sao Paulo Med J"},{"issue":"12","key":"6998_CR30","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1007\/s11695-015-1691-x","volume":"25","author":"G Bower","year":"2015","unstructured":"Bower G, Toma T, Harling L, et al. Bariatric surgery and non-alcoholic fatty liver disease: a systematic review of liver biochemistry and histology. Obes Surg. 2015;25(12):2280\u20139.","journal-title":"Obes Surg"},{"issue":"6","key":"6998_CR31","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s11695-014-1489-2","volume":"25","author":"E Cazzo","year":"2015","unstructured":"Cazzo E, Jimenez LS, Pareja JC, et al. Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study. Obes Surg. 2015;25(6):982\u20135.","journal-title":"Obes Surg"},{"key":"6998_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-230X-6-6","volume":"6","author":"V Ratziu","year":"2006","unstructured":"Ratziu V, Massard J, Charlotte F, et al. LIDO study group; CYTOL study group. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2006;6:6.","journal-title":"BMC Gastroenterol"},{"issue":"11","key":"6998_CR33","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.3390\/jcm10112415","volume":"10","author":"Y Vali","year":"2021","unstructured":"Vali Y, Lee J, Boursier J, et al. Litmus systematic review team. FibroTest for evaluating fibrosis in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis. J Clin Med. 2021;10(11):2415.","journal-title":"J Clin Med"},{"issue":"4","key":"6998_CR34","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2021.04.044","volume":"75","author":"EA Selvaraj","year":"2021","unstructured":"Selvaraj EA, M\u00f3zes FE, Jayaswal ANA, et al. LITMUS investigators. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis. J Hepatol. 2021;75(4):770\u201385.","journal-title":"J Hepatol"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-023-06998-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-023-06998-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-023-06998-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T03:20:41Z","timestamp":1730863241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-023-06998-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["6998"],"URL":"https:\/\/doi.org\/10.1007\/s11695-023-06998-1","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]},"assertion":[{"value":"28 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Lu\u00edsa Souza Echeverria: no conflict of interest.Daniel Leandro Saran Mounzer: no conflict of interest.Martinho Antonio Gestic: no conflict of interest.Murillo Pimentel Utrini: no conflict of interest.Felipe David Mendon\u00e7a Chaim: no conflict of interest.Francisco Callejas-Neto: no conflict of interest.Elinton Adami Chaim: no conflict of interest.Everton Cazzo: no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}